Logo
x

Search

Subscribe Now

SELLAS Life Sciences

SELLAS Reports Updated Results from its P-IIa Study of SLS009 (formerly GFH009) for R/R Acute Myeloid Leukemia (AML)

SELLAS Reports Updated Results from its P-IIa Study of SLS009 (formerly GFH009) for R/R Acute Myeloid Leukemia (AML)

  • January 10, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.